Progesterone and Anxiety in Women: PMS, Perimenopause and Tests

Anxiety in women is often tied to the menstrual cycle phase or perimenopause. 7–10 days before menstruation, during perimenopausal hormone fluctuations, postpartum — these are typical points where anxiety appears or intensifies. The biochemical basis is the fall in progesterone and its metabolite allopregnanolone, which acts on GABA-A receptors like a natural benzodiazepine. Without this "internal tranquilizer," the nervous system stays hyperreactive.

Progesterone as a Natural Tranquilizer

Progesterone is the second-phase menstrual cycle hormone, the principal pregnancy regulator, and at the same time a powerful neurosteroid. Its metabolite allopregnanolone (3α,5α-tetrahydroprogesterone) acts on the same GABA-A receptor as benzodiazepines — diazepam, lorazepam, alprazolam.

This means progesterone functions as an endogenous anxiolytic. When its level drops:

• The GABAergic inhibitory signal weakens
• The nervous system becomes hyperreactive
• Anxiety, emotional lability, insomnia appear
• Stress reactivity heightens

This connection explains several clinical phenomena:

• PMS anxiety — 7–10 days before menstruation, progesterone falls from its luteal peak → "withdrawal" of allopregnanolone → anxiety
• Postpartum anxiety/depression — sharp progesterone drop after birth from pregnancy levels
• Perimenopausal anxiety — progesterone fluctuations as ovulation declines
• Anxiety after hormone therapy withdrawal — if abruptly stopped

Understanding this mechanism allows the search for the cause of anxiety where it often actually lives — in the hormonal cycle.

PMS Anxiety: The Luteal Phase Link

The luteal phase is the second half of the cycle, after ovulation. Normally, on day 21 of the cycle, progesterone peaks (6.9–56.6 nmol/L), and allopregnanolone provides calmness and good sleep.

With luteal insufficiency, progesterone rises insufficiently or falls quickly:

• PMS symptoms appear 7–14 days before menstruation (rather than 1–2 days as in normal)
• The anxious-emotional component dominates: irritability, tearfulness, anxiety, insomnia
• Often short luteal phase (< 12 days)
• Premenstrual spotting 2–4 days before menstruation
• Painful, heavy menstruation

Causes of luteal insufficiency:

• Chronic stress — "progesterone steal" toward cortisol
• Hypothyroidism (TSH > 2.5)
• Hyperprolactinemia
• Polycystic ovary syndrome (PCOS)
• Vitamin D deficiency and low body fat
• Perimenopause

Perimenopause and Waves of Anxiety

Perimenopause begins on average 4–10 years before menopause (i.e., from 40–45 in most women). It is a period of hormonal fluctuations — cycles become irregular, estradiol swings, and progesterone progressively falls as ovulations decline.

Clinical picture:

• "Waves" of anxiety without obvious triggers — anxiety high for several days, then resolves
• Insomnia, especially with awakenings at 3–4 AM
• Mood swings, emotional lability
• Hot flashes (but not in everyone)
• Reduced stress tolerance
• Irritability, episodes of crying

Many women at this stage are diagnosed with "anxiety disorder" by a psychiatrist — and prescribed SSRIs. With a hormonal anxiety driver, SSRIs work partially but don't address the root cause. Laboratory testing at this stage is mandatory.

Progesterone Deficiency: Symptoms in Women

Emotional/nervous symptoms:

• Anxiety, especially in the second half of the cycle
• Insomnia and light sleep before menstruation
• Emotional lability, mood swings
• Irritability, tearfulness
• Reduced stress tolerance
• "Brain fog," distractibility

Somatic symptoms:

• Painful, heavy menstruation
• Short luteal phase (< 12 days)
• Premenstrual spotting
• Breast pain and engorgement
• Edema and premenstrual weight gain
• Infertility, recurrent pregnancy loss

Estrogen dominance symptoms (when progesterone is low relative to estradiol):

• Fibroids, adenomyosis, fibrocystic breast
• Endometriosis
• Endometrial polyps
• Endometrial hyperplasia symptoms

Which Tests to Take

Day-21 progesterone (or 5–7 days before expected menstruation) — luteal phase peak. Target for adequate function: > 25 nmol/L.

Day-21 estradiol — to assess the estradiol/progesterone ratio. Estrogen dominance is diagnosed when progesterone is low against normal or elevated estradiol.

Prolactin — hyperprolactinemia suppresses progesterone.

TSH + free T4 — hypothyroidism impairs corpus luteum function.

Cortisol morning and evening — chronic stress assessment as the cause of "progesterone steal."

Vitamin D — required for steroidogenesis.

Conveniently drawn via sex hormone panel extended with stress hormones (cortisol, DHEA-S) or together with the anxiety causes panel.

The full PMS-anxiety panel: progesterone, estradiol, prolactin, FSH, LH, TSH + free T4, ferritin, cortisol. In 60–70% of women with PMS anxiety, objective abnormalities are found that can be addressed.

When to See a Doctor

To a gynecologist-endocrinologist for:

• Confirmed luteal insufficiency (day-21 progesterone < 16 nmol/L in two cycles)
• Severe PMS with anxiety and/or depressive symptoms
• Infertility and recurrent pregnancy loss
• Perimenopausal anxiety symptoms
• Suspected estrogen dominance

To a psychotherapist/psychiatrist for:

• Persistent anxiety after correcting hormonal abnormalities
• Depressive episodes with suicidal ideation
• Severe social impairment in perimenopause

For more on the female anxiety approach see anxiety: which lab tests and how to lower cortisol in women (on stress and "progesterone steal").

This article is for informational purposes only and does not replace professional medical advice. Progesterone-containing medication is the gynecologist-endocrinologist's prescription.